Health care stocks edged higher Thursday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each adding 0.1%.
The iShares Biotechnology ETF (IBB) rose 0.4%.
In corporate news, Hoth Therapeutics (HOTH) signed an exclusive patent license agreement with the US Department of Veterans Affairs to develop an obesity treatment. The shares fell 2%.
Johnson & Johnson (JNJ) signed an exclusive licensing deal for the global development, manufacturing and commercialization of Kaken Pharmaceutical's STAT6 program for atopic dermatitis and other autoimmune and allergic diseases. Johnson & Johnson shares shed 0.2%.
TScan Therapeutics (TCRX) shares rose 3.3% after the company signed a securities purchase agreement with Lynx1 Capital Management and an investment fund advised by Lynx1 for the sale of $30 million of prefunded warrants.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。